IQE is the leading global outsource supplier of customized epitaxial wafers to the semiconductor industry.

Their technology is of most advanced like AFM means Atomic Force Microscopy and moves a minuscule cantilever over an objects surface, a sharp tip passes over dips or rises punched in the surface and reads out digital information. This technology is not going to slow down it is going to speed up and has to replace most existing forms of memory storage by virtue of capacity and size.

The future of nano-technology, these tiny/minute robots would need very small processors and most sure strained silicon could provide these.

The low share price is due to uncertainty as to when the cash will run out, but I don't think this will happen as cash is of 12 to 15M and NAV of 30p, and losses are going to drop on the next 3 month and we could have profits on the Q4 2004.

Latest news from the Chairman were" The Group remains confident that it is in a strong position within the outsourcing market, although the protection of its cash position is paramount.
With a broad product portfolio allowing the customer base to use IQE as a 'one stop shop', a large available production capacity and a strong balance sheet, the Board believes the Group will benefit strongly as the overall semiconductor industry recovers and will continue to strengthen its position as the leading outsource supplier of advanced wafer products to the sector. "

Nearly all the recent results have been encouraging. Q4 accounts are being completed (30th Dec 2002). IQE know where they stand, if things had got worse their would have been a trading statement by now, and with Amberwave (IQE's partner) increasing its Asian presence, this is a bullish trend and a good point to pick up the shares @ 4.25p

Intraday

5 month MA and Indicators

An interesting patent pending!

"The QR-SPLED industry partners are CST Global and IQE."

CST ?

CST Global

Trading Statement & Notice of Results


Strong growth in H1 revenues marks the start of increased VCSEL wafer demand for mass-market consumer applications, and triggers a capacity expansion to meet higher levels of expected demand in H2 2018.

Cardiff, UK. 20th July 2017: IQE plc (AIM: IQE; "IQE", the "Group"), the leading global supplier of advanced wafer products and wafer services to the semiconductor industry, provides a trading statement for the six months ended 30 June 2017.

The Group announces that it expects to deliver revenues of c. £70m for the first half, reflecting increased sales in each of its three primary markets. Notably, photonics continued to deliver strong double-digit growth, enjoying the early phase of a significant ramp in VCSEL wafer supply for mass market consumer applications. As a result, overall wafer sales are expected to grow by c.16% against H1 2016. This has also been supplemented by c. £1m of license income (H1 2016: £3.5m).

The Group enjoys a broad range of end market drivers, which are increasing the diversity of its wafer sales. The Group is engaged in a range of programmes which provide significant upside potential to its near and mid-term growth expectations. These include VCSEL, GaN for RF and power, full service DFB wafers, InfraRed and cREO(TM). The start of the mass-market ramp for VCSEL wafers marks an inflection point in the commercialisation of this technology. The Group has secured multiple, multi-year contracts for this VCSEL ramp which reflects its strong competitive advantages including its technology leadership and its proven track record in delivering wafers into high volume consumer markets. As a result, the Board has now approved a capacity expansion plan to meet higher levels of expected demand for H2 2018 than previously anticipated. This follows increased investment during H1 2017 in operating costs, product development and working capital to help position the Group for the expected ramp and meet higher levels of growth in H2 of 2017.

As part of its expansion plan the Group announces that it has agreed a heads of terms for the lease of a new premises in South Wales. The lease is with the Cardiff City Region, which has a goal of supporting the development of the Compound Semiconductor Cluster in South Wales. This lease provides the infrastructure needed for IQE's expansion in a highly cost effective manner. The lease is for 11 years, and provides IQE with an option to extend the lease or purchase the freehold. In parallel, the Group has placed orders for new MOCVD equipment.

Following the devaluation of sterling in June 2016, currency provided a tailwind of c.10% year on year, however the impact is largely presentational as the majority of the Group's costs are also denominated in foreign currency.

Notice of Results

The Group expects to report its half-year results for 2017 on 5th September 2017.

Dr Drew Nelson, Chief Executive of IQE, said:

"The first half of 2017 has been a very exciting time for the IQE Group. Overall, all business units have progressed in line with expectations, although the Photonics unit has been the stand out with continued strong double digit growth, accelerating towards the end of the first half. The Group has multiple high growth opportunities ahead, and in order to ensure future capacity is in place in a timely fashion to address H2 2018 and subsequent demand, we have announced an MOU with Cardiff City Region to secure operational facilities in a highly cost effective arrangement, together with initial orders for increased MOCVD capacity. In light of recent progress and its increasingly confident outlook, the Board expects the Group will now exceed market expectations for the full year and whilst it remains early into the start of the mass-market adoption of our technology, it is possible that with the current contract momentum, a more significant upgrade to current market expectations could be delivered for 2018."

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Peel Hunt Buy 92.88 100.00 105.00 Reiterates

In auction with a quid beckoning.

one of my sipp star performers
only bought in feb and march this year and currently +80%

I'm up over 300% on my SIPP holding and just closed a S/B for +23.

very well done indeed skinny
in fact, and to my surprise, i see sp was ~30 only 7/8 months ago

Thanks Cynic - because of the nature of the company when I researched it, I didn't invest a fortune.

Quite a gap now - lets hope its a breakaway gap!

"fortune" is relative :-)

Less than half a percent of my SIPP.

i think mine must be about 2.5% at cost

So my back of a fag packet calculation gives a figure of approx £50,000 for Mr C's investment! Just hope I can sell before he does!!! ;o)

Taken some profit, the rest I will keep very long term!

i'm not that bloody wealthy!
wish i was :-)

IQE surges as it ups guidance and reckons more upgrades could follow

IQE and FEVR are my 2 big whizz-bang sipp investments, the former now having doubled in <6 months

while i don't think i'll be tempted to buy more FEVR, that may not apply with IQE
i shall watch the news with interest

Pop!

It's got the Fevertree fizz!

We should close the day at new recent highs at this rate. Big volume already today.